[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Titel:
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Auteur:
Emmett, Louise Subramaniam, Shalini Crumbaker, Megan Nguyen, Andrew Joshua, Anthony M Weickhardt, Andrew Lee, Sze-Ting Ng, Siobhan Francis, Roslyn J Goh, Jeffrey C Pattison, David A Tan, Thean Hsiang Kirkwood, Ian D Gedye, Craig Rutherford, Natalie K Sandhu, Shahneen Kumar, Aravind Ravi Pook, David Ramdave, Shakher Nadebaum, David P Voskoboynik, Mark Redfern, Andrew D Macdonald, William Krieger, Laurence Schembri, Geoff Chua, Wei Lin, Peter Horvath, Lisa Bastick, Patricia Butler, Patrick Zhang, Alison Yan Yip, Sonia Thomas, Hayley Langford, Ailsa Hofman, Michael S McJannett, Margaret Martin, Andrew James Stockler, Martin R Davis, Ian D